Yaojun Zhang

机构：Xi'an University of Architecture and Technology, Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0002-9752-4729

发表论文 521 篇 · 总被引 12877 次 · h-index 60

代表论文

• LBA2 TALENTACE: A phase III, open-label, randomized study of on-demand transarterial chemoembolization (TACE) combined with atezolizumab + bevacizumab (Atezo+Bev) or on-demand TACE alone in patients with systemically untreated, intermediate-to-high burden unresectable hepatocellular carcinoma (uHCC) (2025 · Annals of Oncology · 被引 38)
• Efflux of N1-acetylspermidine from hepatoma fosters macrophage-mediated immune suppression to dampen immunotherapeutic efficacy (2025 · Immunity · 被引 27)
• Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study (2025 · Journal of Hepatocellular Carcinoma · 被引 8)
• PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy (2025 · Frontiers in Immunology · 被引 6)
• Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma (2025 · Frontiers in Immunology · 被引 5)
• Maximum entropy models for patterns of gene expression (2025 · Physical review. E · 被引 2)